Cevimeline Hydrochloride Capsule
FDA Label NDC 70771-1982

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Cevimeline Hydrochloride (NDC 70771-1982). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

Cevimeline Hydrochloride Capsules, 30 mg

NDC 70771-1982-1 in bottles of 100 capsules with child resistant-closure

Rx Only

Image (7e885fcf 536e 4d43 94c8 2941e9e9a7a2 01)

Image (7e885fcf 536e 4d43 94c8 2941e9e9a7a2 01)

* Please review the disclaimer below.